SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)

Ministry of Health, Labour and Welfare, Japan

Status: Unknown

Conditions: Atrial Fibrillation; Stroke, Acute

Treatments: Other: This is an observational study.

Study type: Observational

Funder types: Other

Identifiers

NCT01581502

samurai nvaf 2011 (Registry Identifier)

samurai2011

Details and patient eligibility

About

The purpose of this study is to determine choice of anticoagulant therapy during acute and chronic stages of ischemic stroke/TIA and short- and long-term outcomes, including stroke recurrence and bleeding complications, in patients having nonvalvular atrial fibrillation.

Enrollment: 1,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Consecutive acute ischemic stroke/TIA patients with NVAF

Exclusion criteria

1. Rheumatic mitral valve disease
2. A history of prosthetic valve replacement or mitral valve surgical repair
3. Active infective endocarditis
4. Patient, family member or legally responsible person does not have given informed consent
5. Inappropriate patient's conditions for study enrollment in the opinion of the investigator

Trial design

1,000 participants in 1 patient group

NVAF, acute ischemic stroke/TIA

Description:

Consecutive acute ischemic stroke/TIA patients with nonvalvular atrial fibrillation; most of these patients begin to receive anticoagulant therapy after index stroke/TIA for secondary prevention

Treatment:

Other: This is an observational study.